In recent years, researchers have shown that HE4 was not only expressed in ovarian cancer, but also in other malignant tumors, such as endometrial carcinoma, lung cancer, breast cancer, gastric cancer and pancreatic cancer 16-19, which was closely correlated with the proliferation, invasion and migration of tumors. Here, WFDC2 is linked to ovarian carcinoma.